Financials
- Market Capitalization 302.93 M
- Employee 86
- Founded 2018
- CEO N/A
- Website www.orchestrabiomed.com
- Headquarter Delaware, United States
- FIGI BBG00W5FR2T5
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-5.2
ratio cours/chiffre d'affaires
6.47
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3252 | IMRX Immuneering Corporation - Class A Common Stock | 4.99 USD | 0.00% | -4.04% | +20.24% | -11.52% | 322.84 M USD | ||
| 3254 | IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.31 USD | -4.15% | -8.70% | +5.48% | +30.51% | 322.33 M USD | ||
| 3317 | IRD Opus Genetics, Inc. - Common Stock | 3.62 USD | -1.90% | -11.06% | -2.69% | -2.69% | 301.17 M USD | ||
| 3322 | FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.89 USD | +1.04% | +0.52% | +7.16% | -39.22% | 296.80 M USD |